These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16856703)

  • 61. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I; Dostal C; Becvar R
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms syndrome in a 35-year-old man with epilepsy.
    Fsadni C; Fsadni P; Piscopo T; Mallia Azzopardi C
    Clin Neuropharmacol; 2008; 31(5):295-8. PubMed ID: 18836349
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
    Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
    J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Chest pain, reduced physical activity, and polyserositis in a 35-year old patient with anticonvulsive medication].
    Wittchen F; Spencker S; Zinke S; Coban N; Schultheiss HP; Witzenbichler B
    Internist (Berl); 2006 Jan; 47(1):69-75. PubMed ID: 16283138
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Carbamazepine-induced hypersensitivity syndrome in chronic schizophrenia.
    Pan CW; Yu CH; Liao DL
    Gen Hosp Psychiatry; 2013; 35(5):575.e9-10. PubMed ID: 23153842
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Carbamazepine intolerance mimicking infectious mononucleosis: apropos of 3 cases].
    Merle De Boever C; Sotto A; Guillot B; Jourdan J
    Therapie; 1999; 54(4):489-91. PubMed ID: 10667117
    [No Abstract]   [Full Text] [Related]  

  • 67. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Systemic lupus erythematosus in the elderly.
    Rovenský J; Tuchynová A
    Autoimmun Rev; 2008 Jan; 7(3):235-9. PubMed ID: 18190884
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lupus cystitis: a case report and review of the literature.
    Shimizu A; Tamura A; Tago O; Abe M; Nagai Y; Ishikawa O
    Lupus; 2009 Jun; 18(7):655-8. PubMed ID: 19433468
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S; Pereira DA; Costallat LT
    Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Carbamazepine induced systemic lupus erythematosus: case report.
    Bateman DE
    Br Med J (Clin Res Ed); 1985 Sep; 291(6496):632-3. PubMed ID: 3928057
    [No Abstract]   [Full Text] [Related]  

  • 72. Systemic lupus erythematosus in a patient with primary MALT lymphoma of the larynx.
    Gonzàlez N; Xicoy B; Olivé A; Jové J; Ribera JM; Feliu E
    Ear Nose Throat J; 2009 Aug; 88(8):E4-5. PubMed ID: 19688705
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rare association of multiple sclerosis and systemic lupus erythematosus.
    Kyrozis A; Kararizou E; Georgila E; Loukaidis PN; Koureas A; Rombos A; Sfagos C; Vassilopoulos D
    Lupus; 2007; 16(12):991-2. PubMed ID: 18042594
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An unusual multiplex systemic lupus erythematosus family with high prevalence of nephropathy, late-onset disease, and one member with disease-onset post-HIV therapy.
    Jakez-Ocampo J; Carrillo-Maravilla E; Richaud-Patin Y; Soto-Vega E; Atisha-Fregoso Y; Llorente L
    J Clin Rheumatol; 2008 Feb; 14(1):34-7. PubMed ID: 18431097
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Severe clinical course of systemic lupus erythematosus in the first year of life.
    Zulian F; Pluchinotta F; Martini G; Da Dalt L; Zacchello G
    Lupus; 2008 Sep; 17(9):780-6. PubMed ID: 18755858
    [TBL] [Abstract][Full Text] [Related]  

  • 76. B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus.
    Podolskaya A; Stadermann M; Pilkington C; Marks SD; Tullus K
    Arch Dis Child; 2008 May; 93(5):401-6. PubMed ID: 18039744
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management.
    Aloush V; Litinsky I; Caspi D; Elkayam O
    Semin Arthritis Rheum; 2006 Aug; 36(1):4-9. PubMed ID: 16887463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Quinidine-induced rheumatic toxicity].
    Almoznino-Sarafian D; Cohen N; Zaidenstein R; Dishi V; Zeckler E
    Harefuah; 1997 Mar; 132(6):404-7, 447. PubMed ID: 9153856
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lovastatin-induced lupus erythematosus.
    Ahmad S
    Arch Intern Med; 1991 Aug; 151(8):1667-8. PubMed ID: 1872674
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus.
    Kur JK; Esdaile JM
    J Rheumatol; 2006 Nov; 33(11):2178-83. PubMed ID: 16960925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.